Hong Kong-listed Huajian Medical rises another 9% intraday, with a cumulative gain of over 200% in the past four weeks

According to ChainCatcher, Hong Kong-listed company Huajian Medical (01931.HK) surged another 9% during trading, with a cumulative increase of over 200% in the past four weeks. As of press time, the stock was up 7.3% at HKD 6.17, with a trading volume of HKD 23.32 million.

ChainCatcher previously reported that at the end of July, Huajian Medical announced the signing of a strategic cooperation framework agreement with BGI CoWin to jointly establish the Huajian-BGI CoWin Innovative Drug Intellectual Property Tokenization Fund (IVD-BGI CoWin).